Proton pump inhibitors (PPIs) are among the most frequently prescribed medications. Their
use is likely even higher than estimated due to an increase in the number of PPIs available …

AIM To perform a systematic review and meta-analysis on proton pump inhibitors (PPIs)
therapy and the risk of Clostridium difficile infection (CDI). METHODS We conducted a …

Background Gastroprotectant drugs are used for the prevention and treatment of peptic ulcer
disease and might reduce its associated complications, but reliable estimates of the effects …

Proton pump inhibitors (PPIs) potently inhibit gastric acid secretion and are widely used for
treatment of acid-related diseases including gastroesophageal reflux disease and …

Proton-pump inhibitors (PPIs) are a widely prescribed class of medications used to treat acid-
related disorders and use has significantly increased over the last few decades. PPIs are …

Proton pump inhibitors are among the most commonly prescribed classes of drugs, and their
use is increasing, in particular for long‐term treatment, often being over‐prescribed and …

Medications are a common cause of AKI, especially for patients admitted to hospital wards
and the intensive care unit. Although drug-related kidney injury occurs through different …

Background Existing epidemiological studies illustrate that proton pump inhibitors (PPIs)
may be related to adverse kidney outcomes. To date, no comprehensive meta-analysis has …

Background & Aims Proton pump inhibitors (PPI) have been associated with acute kidney
injury and recent studies suggest that they may be associated with the risk of chronic kidney …

Proton pump inhibitors (PPIs), long thought to be safe, are associated with a number of
nonkidney adverse health outcomes and several untoward kidney outcomes, including …